Thermo Fisher Scientific Extends Tender Offer for Dionex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Thermo Fisher Scientific today announced it has extended its $2.1 billion offer to purchase Dionex.

Its offer to acquire all outstanding shares of the chromatography firm at $118.50 per share is now set to expire at midnight EDT Feb. 17. All other terms of the deal remain, the company said, adding the acquisition is anticipated to be completed later this quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.